Fresh analysis reveals that people who come off blockbuster GLP-1 drugs like Wegovy and Mounjaro tend to recover reduced body mass far faster than those who end conventional diet and exercise plans.
Findings released in a major medical journal demonstrates that while obese people often shed a large proportion of their total mass while on the medication, the mass returns at an estimated rate of nearly a kilo each month after stopping.
"Individuals using such drugs need to be cognizant of the potential of quick rebound weight gain when the treatment ends," cautioned expert Dr. Susan Jebb.
Such speed of recovery suggests a return to pre-treatment weight within about one and a half years.
Weighing Approaches
The study, which reviewed 37 of trials involving thousands of participants, compared the effects of these new drugs with older methods.
Researchers emphasize that people who lose weight through diet and exercise generally see a more gradual weight regain—approximately 100 grams monthly—post-intervention.
Understanding the Rapid Regain
Experts propose the way of the injections is key to understanding the amplified weight return.
The injections copy a body's own chemical called glucagon-like peptide-1, which controls feelings of fullness.
"Artificially providing the hormone levels several times higher than the body's typical production may cause the system to produce less of its endogenous GLP-1, and could reduce sensitivity to its effects," said Dr. Adam Collins, a nutrition researcher.
"Withdrawal of this GLP-1 'fix' means appetite is unsuppressed, making overeating far more likely."
An Ongoing Condition?
Medical guidelines recommend the injections for people with weight-linked health risks, alongside prescribed diet and exercise modifications.
Professionals say that, considering the significant potential of relapse, the therapy should be considered ongoing.
This perspective is echoed by pharmaceutical companies, who state that the findings "highlight the long-term character of excess weight," akin to managing conditions like hypertension.
User Testimonies
Users who have stopped the medication report a sudden return of appetite.
"It was like a trigger activating and you're instantly ravenous," described a patient.
This challenge is compounded if individuals have not established lasting dietary or behavioural modifications during therapy.
Significant Interest
Recent estimates show that millions of people in the UK have tried these injections in the past year, with demand being substantial.
- Adoption is higher among women than men.
- The 40s and 50s age group shows the greatest level of interest.
- Many obtain the drugs through private healthcare rather than public health services.
Finally, researchers emphasize that while these medications are effective agents for shedding pounds, they are not a standalone fix and lasting health benefits likely depends on integrated lifestyle changes.